Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000376212

Medchemexpress LLC Zm323881 (hydrochloride) | 193000-39-4 | C22H19ClFN3O2 | 50 MG
SDP

Catalog No. 5000376212
Encompass_Preferred

ZM323881 hydrochloride is a potent and selective VEGFR2 inhibitor with an IC50 of less than 2 nM. It is an anilinoquinazoline that potently inhibits VEGFR2 (KDR) tyrosine kinase activity, demonstrating excellent selectivity versus other receptor tyrosine kinases. It inhibits VEGF-A-induced endothelial cell proliferation (IC50=8 nM) and VEGFR2 tyrosine phosphorylation, making it suitable for research applications.

  • Potent and selective VEGFR2 inhibitor
  • Anilinoquinazoline structure
  • Inhibits VEGF-A-induced endothelial cell proliferation
  • Inhibits VEGFR2 tyrosine phosphorylation
  • For research use only

Catalog No. 50-003-76212 Supplier Medchemexpress LLC Supplier No. HY15467A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ZM323881 hydrochloride is a potent and selective VEGFR2 inhibitor with an IC50 of less than 2 nM. It is an anilinoquinazoline that potently inhibits VEGFR2 (KDR) tyrosine kinase activity, demonstrating excellent selectivity versus other receptor tyrosine kinases. It inhibits VEGF-A-induced endothelial cell proliferation (IC50=8 nM) and VEGFR2 tyrosine phosphorylation, making it suitable for research applications.

  • Potent and selective VEGFR2 inhibitor
  • Anilinoquinazoline structure
  • Inhibits VEGF-A-induced endothelial cell proliferation
  • Inhibits VEGFR2 tyrosine phosphorylation
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.